CD8A and myelodysplastic syndrome: Here, we report antigen-specific CD8+ T cell response induced by BNT162b2 COVID-19 mRNA vaccine up to six months post-vaccination, and provide a detailed characterization of T cell immunodominance, immunological memory, and impact of the booster immunization in CLL and MDS patients.